Latest news with #MDT
Yahoo
2 days ago
- Business
- Yahoo
Why Medtronic (MDT) is One of the Most Trusted Safe Dividend Stocks in Healthcare
Medtronic plc (NYSE:MDT) is included among the 10 Best and Safe Dividend Stocks to Buy Now. A surgeon in a modern operating room holding advanced medical devices with a sense of purpose and accuracy. The company showcases solid financial health with steady revenue, strong free cash flow, and reliable earnings. Its current dividend payout ratio stands at 53.14%, well below its 10-year average, indicating stronger earnings coverage. MDT remains committed to innovation, allocating $1.85 billion to advance technologies in cardiac care, diabetes, and surgical solutions, while also expanding its footprint in emerging markets and the Asia-Pacific region. Offering a broad portfolio that spans cardiovascular, neuroscience, medical-surgical, and diabetes care, Medtronic plc (NYSE:MDT) integrates artificial intelligence and robotics to enhance its products. The company also plans to spin off its diabetes segment into a separate entity to unlock shareholder value. With just two more dividend increases, Medtronic plc (NYSE:MDT) is on track to achieve Dividend King status. The company has grown its dividends for 48 years in a row. Currently, it offers a quarterly dividend of $0.71 per share and has a dividend yield of 3.06%, as of July 27. While we acknowledge the potential of MDT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio
Business Upturn
3 days ago
- Business
- Business Upturn
Top Losers in Crypto in the last 24 hours: FIS falls 16.15% as market corrections hit low-cap assets
The crypto market took a breather today. While some tokens saw healthy gains, others weren't as lucky. Many smaller-cap tokens faced pressure, showing signs of sell-offs or short-term corrections. Traders seem to be locking in profits or moving to safer bets after recent rallies. Here's a look at the coins that dropped the most in the past 24 hours. Top Losers in Crypto in the last 24 hours FIS At the top of the losers list, FIS saw the steepest fall, plunging by 16.15%. It now trades at $0.1334. This sharp decline could indicate reduced demand or big holders offloading their bags. FIS had been gaining traction recently, so this dip may just be a market reset. MDT Next up, MDT fell by 14.57%, bringing its price down to $0.03025. The drop came without any major news, suggesting it could be part of a broader risk-off sentiment in altcoins. MDT often moves quietly, so a correction like this may attract short-term buyers soon. GLM GLM also faced heavy selling, sliding 13.83% to $0.2997. It had shown strength earlier this month, so today's red candle might just be the aftermath of that run-up. Unless the trend continues, this could be a healthy retracement. BIFI In the high-value token category, BIFI lost 9.78% and now stands at $207.60. The coin tends to see large swings, but this fall was significant even by its standards. It could be tied to liquidity movement or sudden large sells. Other notable coins OMNI was down 8.79%, closing at $2.80. No major announcements surfaced, but the drop lines up with general weakness in low-volume tokens. Similarly, CVX fell by 8.21%, settling at $5.55. The correction might reflect uncertainty among DeFi-related assets, especially with shifting sentiment in the broader ecosystem. T, also known as Threshold, slipped 8.14%, now at $0.0185. This follows a modest gain streak earlier in the week. Its decline could be temporary, especially if on-chain metrics remain stable. SPK dropped by 7.31%, currently trading at $0.0942, while REI came in just below with a 7.28% loss, now at $0.0219. These dips aren't uncommon for micro-cap tokens. Finally, IDEX finished the top 10 loser list with a 6.91% decline, closing at $0.03179. Altogether, today's losers reflect a shift in trader attention. Investors appear to be rotating out of high-risk tokens, at least for the moment. With many of these coins coming off recent highs, today's red numbers could simply be part of a routine market cooldown rather than panic.
Vogue Arabia
6 days ago
- Health
- Vogue Arabia
Have You Tried Cycle Syncing Yet?
The menstrual cycle impacts nearly everything — mood, energy, appetite, weight, productivity, and behaviour — everything. As much as we like to feel in control, hormones often take the lead and run the show. Considering they play such a central role in the female body, instead of ignoring them, it makes sense to listen and plan accordingly. And that's where cycle syncing comes in. It's a form of biohacking that understands and works with your body, and involves aligning your lifestyle decisions based on the phases of your menstrual cycle. 'When you start syncing your lifestyle to your cycle, you stop feeling like you're 'all over the place' every week,' explains Mitun De Sarkar, UAE-based clinical dietitian. Instead of viewing your period as an isolated event, cycle syncing is about honouring the entire cycle, believes integrative nutritionist and health psychologist, Karishma Shah. 'It recognises hormones, mood, energy, and the metabolism shift each week, and so should your lifestyle,' she adds. 'Cycle syncing helps you understand when to lean in, when to pull back, and how to nourish your body in a way that supports hormonal harmony.' Read More Are we Overdosing on Health and Beauty Supplements? The sudden surge in nutraceuticals has got people reaching out for pills and powders instead of real food The benefits This technique offers a range of benefits — from reducing PMS and improving fertility to balancing mood, boosting energy, enhancing skin quality, and supporting weight management. 'It helps women train smarter, not harder, by aligning with the body's changing biomechanics, fatigue levels, and joint stability across each phase,' says Dr Karishma Sanghavi, sports physiotherapist and certified MDT from McKenzie Institute India. Even in skincare, it promotes greater body awareness. Dr Anjali Mahto, consultant dermatologist and founder of Self London, notes that while research is still emerging, there's biological plausibility behind hormone fluctuations affecting the skin. 'By tracking these shifts and adjusting skincare accordingly, individuals may better manage concerns like oiliness, breakouts, sensitivity, or dullness,' she explains. Read More 3 Simple Rules for a Healthy Gut Beyond its well-known digestive functions, the microbiota plays a role in regulating our entire metabolism. It may modify our mood and even our gene expression. What if it were possible to optimise it with raw food? Taking the wheel: a guide to cycle syncing Menstrual phase (Day 1 - 5) Oestrogen and progesterone are at their lowest; the body is in rest-and-release mode, shedding the uterine lining with low energy levels.
Filipino Times
7 days ago
- Politics
- Filipino Times
Trump to Visit Manila for 2026 ASEAN Summit
United States President Donald Trump has confirmed his attendance at the 44th ASEAN Summit to be hosted by the Philippines in 2026, Philippine Ambassador to the U.S. Jose Manuel Romualdez revealed in an interview with NewsWatch Plus. The commitment came during a conversation between the two following an official luncheon held in Washington as part of President Ferdinand Marcos Jr.'s recent visit to the United States. Romualdez recalled asking Trump directly if he would attend the summit in Manila. 'Yes, I will definitely go,' Trump reportedly replied, according to the ambassador. Trump had previously stated in the Oval Office during a media engagement, 'If I'm invited, I'll go.' President Marcos formally extended the invitation, solidifying expectations that Trump will visit the country as part of the summit. The Philippines is set to host the 44th ASEAN Summit in 2026, which will coincide with two major milestones in PH-U.S. relations—the 80th anniversary of diplomatic ties and the 75th year of the Mutual Defense Treaty (MDT). The high-level summit will serve as a platform to strengthen regional cooperation and reaffirm longstanding alliances among member states and key partners like the United States. In his arrival statement from Washington, President Marcos described Trump's anticipated visit as a 'reaffirmation of our historic alliance.' He emphasized the importance of U.S.-Philippine relations, noting that the Mutual Defense Treaty remains a key pillar of the country's security framework. 'The United States is our oldest and only treaty ally,' Marcos said. 'This visit and summit will mark another chapter in our shared strategic interests.' Ask ChatGPT
Yahoo
7 days ago
- Business
- Yahoo
Here's What to Expect From Medtronic's Next Earnings Report
Galway, Ireland-based Medtronic plc (MDT) designs, manufactures, and distributes a wide range of medical devices, therapies, and digital health solutions used to treat chronic and complex health conditions across global healthcare systems. Valued at a market cap of $118 billion, the company is committed to advancing medical technology to alleviate pain, restore health, and extend life. It is scheduled to announce its fiscal Q1 earnings for 2026 before the market opens on Tuesday, Aug. 19. Before this event, analysts project this healthcare giant to report a profit of $1.23 per share, in line with the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in each of the last four quarters. Its earnings of $1.62 per share in the previous quarter outpaced the consensus estimates by 2.5%. More News from Barchart NVDA Broken Wing Butterfly Trade Targets A Profit Zone Between 150 and 160 Is Opendoor Stock a Buy at New 52-Week Highs? Billionaire Peter Thiel is Betting Big on Stablecoins. Should You Buy the "MicroStrategy of Ethereum," Too? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! For the full year, analysts expect MDT to report EPS of $5.55, up 1.1% from $5.49 per share in fiscal 2025. Furthermore, its EPS is expected to grow 7.9% year-over-year to $5.99 in fiscal 2027. MDT has rallied 15.9% over the past 52 weeks, outpacing both the S&P 500 Index's ($SPX) 14.5% uptick and the Health Care Select Sector SPDR Fund's (XLV) 8.3% drop over the same time frame. Despite delivering stronger-than-expected results, shares of Medtronic plunged 2.3% after its Q4 earnings release on May 21. The company's revenue improved 3.9% year-over-year to $8.9 billion, topping consensus estimates by 1.1%. Moreover, its adjusted EPS of $1.62 advanced nearly 11% from the year-ago quarter and came in 2.5% above the analyst expectations. Looking ahead to fiscal 2026, Medtronic expects adjusted EPS in the range of $5.50 to $5.60, and anticipates organic sales growth of approximately 5%. Wall Street analysts are moderately optimistic about MDT's stock, with an overall "Moderate Buy" rating. Among 30 analysts covering the stock, 13 recommend "Strong Buy," one indicates a "Moderate Buy," 15 advise 'Hold,' and one suggests a "Strong Sell' rating. The mean price target for Medtronic is $95.83, implying a 4.2% premium from the current levels. On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
